Patents matching “formulation”

US 9382317

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Jul 5, 2016 · Expires Jun 30, 2036

US 9375403

Formulations of 6-mercaptopurine

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 28, 2016 · Expires Jun 23, 2036

US 9375402

Oral formulations of kinase inhibitors

VERASTEM, INC. · Granted Jun 28, 2016 · Expires Jun 23, 2036

US 9364563

Methods and compositions for liposomal formulation of antigens and uses thereof

The Regents of the University of California · Granted Jun 14, 2016 · Expires Jun 9, 2036

US 9358204

Formulations of viloxazine

Supernus Pharmaceuticals, Inc. · Granted Jun 7, 2016 · Expires Jun 2, 2036

US 9352027

Albumin-free factor VIII formulations

UNIVERSITY OF CONNECTICUT · Granted May 31, 2016 · Expires May 26, 2036

US 9353240

Elastomer formulations comprising discrete carbon nanotube fibers

MOLECULAR REBAR DESIGN, LLC · Granted May 31, 2016 · Expires May 26, 2036

US 9346880

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted May 24, 2016 · Expires May 19, 2036

US 9340594

VEGF antagonist formulations for intravitreal administration

REGENERON PHARMACEUTICALS, INC. · Granted May 17, 2016 · Expires May 12, 2036

US 9339545

Stable formulations for parenteral injection of peptide drugs

XERIS PHARMACEUTICALS, INC. · Granted May 17, 2016 · Expires May 12, 2036

US 9340611

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted May 17, 2016 · Expires May 12, 2036

US 9340612

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted May 17, 2016 · Expires May 12, 2036

US 9333244

Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia

HALOZYME, INC. · Granted May 10, 2016 · Expires May 5, 2036

US 9308249

Norovirus vaccine formulations

Takeda Vaccines, Inc. · Granted Apr 12, 2016 · Expires Apr 7, 2036

US 9307783

Drinking water formulation and method and article relating to same

ESSENTIALIFE HOMEOPATHICS · Granted Apr 12, 2016 · Expires Apr 7, 2036

US 9308182

Parenteral formulations of rasagiline

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 12, 2016 · Expires Apr 7, 2036

US 9301920

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Apr 5, 2016 · Expires Mar 31, 2036

US 9302002

Etanercept formulations stabilized with combinations of sugars and polyols

Coherus BioSciences, Inc. · Granted Apr 5, 2016 · Expires Mar 31, 2036

US 9302010

Stable formulations for parenteral injection of peptide drugs

XERIS PHARMACEUTICALS, INC. · Granted Apr 5, 2016 · Expires Mar 31, 2036

US 9295724

Stable formulations for parenteral injection of peptide drugs

XERIS PHARMACEUTICALS, INC. · Granted Mar 29, 2016 · Expires Mar 24, 2036

US 9272028

Norovirus vaccine formulations

Takeda Vaccines, Inc. · Granted Mar 1, 2016 · Expires Feb 25, 2036

US 2016051546

CRYSTALLIZATION PROCESS OF ARIPIPRAZOLE DERIVATIVES IN EXTENDED RELEASE FORMULATIONS FOR TREATMENT OF SCHIZOPHRENIA

ALKERMES PHARMA IRELAND LTD [IE] · Granted Feb 25, 2016 · Expires Feb 20, 2036

US 9254262

Dosage and formulation

Almirall, S.A. · Granted Feb 9, 2016 · Expires Feb 4, 2036

US 9241896

Methods and formulations for treating sialic acid deficiencies

Ultragenyx Pharmaceutical Inc. · Granted Jan 26, 2016 · Expires Jan 21, 2036